Please use this identifier to cite or link to this item:
http://hdl.handle.net/10553/44599
| Title: | Association of Tryptophan Metabolites with Incident Type 2 Diabetes in the PREDIMED Trial: A Case-Cohort Study | Authors: | Yu, Edward Papandreou, Christopher Ruiz-Canela, Miguel Guasch-Ferre, Marta Clish, Clary B. Dennis, Courtney Liang, Liming Corella, Dolores Fitó, Montserrat Razquin, Cristina Lapetra, José Estruch, Ramón Ros, Emilio Cofán, Montserrat Arós, Fernando Toledo, Estefania Serra-Majem, Lluis Sorlí, José V. Hu, Frank B. Martinez-Gonzalez, Miguel A. Salas-Salvado, Jordi |
UNESCO Clasification: | 2403 Bioquímica 2301 química analítica |
Keywords: | Diabetes Insulin Metabolites Risk analysis Cardiovascular disease |
Issue Date: | 2018 | Publisher: | 0009-9147 | Journal: | Clinical chemistry (Baltimore, Md.) | Abstract: | BACKGROUND: Metabolites of the tryptophan-kynurenine pathway (i.e., tryptophan, kynurenine, kynurenic acid, quinolinic acid, 3-hydroxyanthranilic) may be associated with diabetes development. Using a case-cohort design nested in the Prevencion con Dieta Mediterranea (PREDIMED) study, we studied the associations of baseline and 1-year changes of these metabolites with incident type 2 diabetes (T2D). | URI: | http://hdl.handle.net/10553/44599 | ISSN: | 0009-9147 | DOI: | 10.1373/clinchem.2018.288720 | Source: | Clinical Chemistry [ISSN 0009-9147], v. 64 (8), p. 1211-1220 |
| Appears in Collections: | Artículos |
SCOPUSTM
Citations
71
checked on Apr 21, 2024
WEB OF SCIENCETM
Citations
67
checked on Feb 25, 2024
Page view(s)
34
checked on Sep 16, 2023
Google ScholarTM
Check
Altmetric
Share
Export metadata
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.